Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

NCT00722189 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2023-06-09

No results posted yet for this study

Summary

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Conditions

  • Skin Mycoses

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY
  • LEO Pharma

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-01-31
Completion
2009-02-28

Countries

  • Russia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00722189 on ClinicalTrials.gov